Since its creation in 2010, the Canadian Partnership for Quality Radiotherapy (CPQR) has made meaningful progress in advancing quality and safety in radiotherapy across Canada. Through close collaboration with provincial cancer agencies and programs, CPQR has developed pan-Canadian guidelines, led…
Featured Item: Show on home page
Nobody wants to see the delivery of life-saving radiotherapy treatment disrupted, for any reason. Unfortunately, cyberattacks, environmental hazards and technical failures are among the numerous unplanned interruptions that can and do happen and can lead to prolonged downtime.
These disruptions…
2026-03-25
In 2024, the Canadian Partnership Against Cancer (CPAC) and the Canadian Cancer Society published a Pan-Canadian Cancer Data Strategy to help strengthen how cancer data are collected, shared, and used across Canada.
As part of this…
The 2024-25 annual report from the Pan-Canadian Cancer Genomics Community of Practice showcases achievements throughout the year and details next steps toward equitable, standardized biomarker testing.
Members of the Pan-Canadian Cancer Genomics Community of Practice contributed to the development of a consensus-based assessment framework to support the standardized, efficient, and transparent evaluation of molecular, genetic, and genomic biomarkers in cancer care in Canada.
The pan-Canadian Quality Assurance in Radiopharmaceutical Therapy (pCQRT) advisory committee — one of CAPCA’s standing committees — recently met to set its upcoming priorities.
This marks the committee’s first multi-year work plan and outlines how pCQRT will help support safe,…
